oxprenolol has been researched along with Arrhythmias, Cardiac in 40 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day." | 9.05 | Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980) |
| "In 736 patients, 24 hour electrocardiographic recordings were performed 14 to 36 days after acute myocardial infarction before the start of randomized treatment with 320 mg of slow release oxprenolol (n = 358) or placebo (n = 378)." | 9.05 | Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1985) |
| "Authors have analyzed the antiarrhythmic effect of oxprenolol, a beta blocking agent, in the treatment of various types of arrhythmias and in the prophylaxis of recurrences of auricular flutter and fibrillation." | 9.04 | [Oxprenolol in the treatment and prevention of cardiac arrhythmias]. ( Camerini, F; Crepaldi, L; Martinoli, E; Medugno, G; Scardi, S, 1975) |
| "The role of the cardiac beta receptor in the genesis and perpetuation of ouabain-induced ventricular tachyarrhythmias (VT) was investigated in the chloralose (20 mg/kg)-urethane (200 mg/kg) anesthetized dog." | 7.65 | Effect of beta receptor blockade on the initiation and perpetuation of ouabain-induced ventricular tachyarrhythmia. ( Apantaku, FO; Baumgarten, CM; Ten Eick, RE, 1975) |
| "Oxprenolol, a new beta-receptor blocking drug with intrinsic sympathomimetic activity, was used to treat 63 episodes of cardiac arrhythmia occurring in 43 patients with acute myocardial infarction or myocardial ischaemia." | 7.65 | Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia. ( Pistevos, AC; Sandler, G, 1971) |
| "Then experimental arrhythmias were induced by methacholine or adrenaline (Adr) on RWIS mice, and their frequencies of appearance were examined." | 5.27 | [Abnormal ECG and adrenaline-induced arrhythmias in restraint and water immersion stressed mice and effects of oxprenolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "Oxprenolol and carteolol were observed to have mild effects on the abnormal ECG as compared with propranolol." | 5.27 | [The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "As for two-stage coronary ligation arrhythmia, oxprenolol suppressed only that observed 48 hours after coronary ligation using higher doses (5 to 10 mg/kg)." | 5.26 | Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs. ( Hashimoto, K; Imai, S; Matsubara, I; Matsuda, H; Tsukada, T, 1978) |
| "473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day." | 5.05 | Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980) |
| "In 736 patients, 24 hour electrocardiographic recordings were performed 14 to 36 days after acute myocardial infarction before the start of randomized treatment with 320 mg of slow release oxprenolol (n = 358) or placebo (n = 378)." | 5.05 | Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1985) |
| "Authors have analyzed the antiarrhythmic effect of oxprenolol, a beta blocking agent, in the treatment of various types of arrhythmias and in the prophylaxis of recurrences of auricular flutter and fibrillation." | 5.04 | [Oxprenolol in the treatment and prevention of cardiac arrhythmias]. ( Camerini, F; Crepaldi, L; Martinoli, E; Medugno, G; Scardi, S, 1975) |
| " Oxprenolol was the most potent antagonist of the isoprenaline induced cardiac arrhythmias." | 3.65 | Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits. ( Darabi, MK; Hague, MA; Khalighi, MR, 1977) |
| "The role of the cardiac beta receptor in the genesis and perpetuation of ouabain-induced ventricular tachyarrhythmias (VT) was investigated in the chloralose (20 mg/kg)-urethane (200 mg/kg) anesthetized dog." | 3.65 | Effect of beta receptor blockade on the initiation and perpetuation of ouabain-induced ventricular tachyarrhythmia. ( Apantaku, FO; Baumgarten, CM; Ten Eick, RE, 1975) |
| "Oxprenolol, a new beta-receptor blocking drug with intrinsic sympathomimetic activity, was used to treat 63 episodes of cardiac arrhythmia occurring in 43 patients with acute myocardial infarction or myocardial ischaemia." | 3.65 | Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia. ( Pistevos, AC; Sandler, G, 1971) |
| "Oxprenolol is a potent noncardioselective beta-adrenoceptor blocking drug with partial agonist activity of proved efficacy and high tolerability in patients at risk of various cardiovascular disease syndromes." | 2.36 | Oxprenolol in clinical practice. ( Taylor, SH, 1983) |
| "Consecutive arrhythmias (ventricular pairs and runs of ventricular premature beats) and left-ventricular dysfunction alone were associated with a low mortality of 4." | 1.28 | Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1990) |
| "Then experimental arrhythmias were induced by methacholine or adrenaline (Adr) on RWIS mice, and their frequencies of appearance were examined." | 1.27 | [Abnormal ECG and adrenaline-induced arrhythmias in restraint and water immersion stressed mice and effects of oxprenolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "Oxprenolol and carteolol were observed to have mild effects on the abnormal ECG as compared with propranolol." | 1.27 | [The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol]. ( Harada, N; Hata, T; Itoh, E; Kita, T, 1984) |
| "As for two-stage coronary ligation arrhythmia, oxprenolol suppressed only that observed 48 hours after coronary ligation using higher doses (5 to 10 mg/kg)." | 1.26 | Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs. ( Hashimoto, K; Imai, S; Matsubara, I; Matsuda, H; Tsukada, T, 1978) |
| "Oxprenolol or pindolol were used as primary drugs in 8 cases." | 1.26 | [Therapy of postoperative arrhythmias (author's transl)]. ( Vormittag, E, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 39 (97.50) | 18.7374 |
| 1990's | 1 (2.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilcox, RG | 1 |
| Rowley, JM | 1 |
| Hampton, JR | 1 |
| Mitchell, JR | 1 |
| Roland, JM | 1 |
| Banks, DC | 1 |
| Frishman, WH | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Krämer, B | 1 |
| Kübler, W | 1 |
| Kita, T | 2 |
| Hata, T | 2 |
| Harada, N | 2 |
| Itoh, E | 2 |
| Taylor, SH | 1 |
| Shanks, RG | 1 |
| Hague, MA | 1 |
| Darabi, MK | 1 |
| Khalighi, MR | 1 |
| Szegl, J | 1 |
| Szabó, J | 1 |
| Szentmiklósi, J | 1 |
| Harsányi, K | 1 |
| Korbonits, D | 1 |
| Lüderitz, B | 1 |
| Hashimoto, K | 1 |
| Tsukada, T | 1 |
| Matsuda, H | 1 |
| Matsubara, I | 1 |
| Imai, S | 1 |
| Martinoli, E | 1 |
| Medugno, G | 1 |
| Crepaldi, L | 1 |
| Scardi, S | 1 |
| Camerini, F | 1 |
| Vormittag, E | 1 |
| Apantaku, FO | 1 |
| Baumgarten, CM | 1 |
| Ten Eick, RE | 1 |
| Frisch, P | 1 |
| Contino, A | 1 |
| Elliott, HL | 1 |
| Campbell, BC | 1 |
| Morgan, I | 1 |
| Pongiglione, R | 1 |
| Ruffa, G | 1 |
| Di Biase, M | 1 |
| Guglielmi, R | 1 |
| Scarcia, A | 1 |
| Chiddo, A | 1 |
| Rizzon, P | 1 |
| Dubova, MN | 1 |
| Zisel'man, SB | 1 |
| Pankratov, AB | 1 |
| Crook, BR | 1 |
| Cashman, PM | 1 |
| Sukenik, S | 1 |
| Cristal, N | 1 |
| Miyazaki, M | 1 |
| Nioka, S | 1 |
| Fujita, T | 1 |
| Brooks, NH | 1 |
| Andresen, D | 2 |
| Bethge, KP | 2 |
| Boissel, JP | 2 |
| von Leitner, ER | 2 |
| Peyrieux, JC | 2 |
| Schröder, R | 3 |
| Tietze, U | 2 |
| Zamotaev, IP | 2 |
| Lozinskiĭ, LG | 2 |
| Sandomirskiĭ, BL | 2 |
| Gross, F | 1 |
| Lawrence, T | 1 |
| Frankl, WS | 1 |
| Votchal, BE | 1 |
| Vorob'eva, ZV | 1 |
| Gettes, LS | 1 |
| Singh, BN | 2 |
| Offerhaus, L | 1 |
| Jewitt, DE | 1 |
| Goch, JH | 1 |
| Fomina, AA | 1 |
| Spivak, AM | 1 |
| Mironova, KA | 1 |
| Reingardt, BK | 1 |
| Myburgh, DP | 1 |
| Broustet, P | 1 |
| Lacut, JY | 1 |
| Sandler, G | 1 |
| Pistevos, AC | 1 |
8 reviews available for oxprenolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
[Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Death | 1984 |
Oxprenolol in clinical practice.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Heart Rate; Humans; Hyperte | 1983 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias | 1973 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillatio | 1970 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
7 trials available for oxprenolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Disopyra | 1980 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
[Oxprenolol in the treatment and prevention of cardiac arrhythmias].
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature | 1975 |
Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Delayed-A | 1985 |
[Treatment of disorders of cardiac rhythm with beta-adrenoblockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Tri | 1985 |
Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Animals; Arrhythmias, Cardiac; Clinical Trials as Topic; D | 1985 |
Oxprenolol and ventricular ectopic activity of the heart.
Topics: Arrhythmias, Cardiac; Attitude to Health; Clinical Trials as Topic; Humans; Myocardial Infarction; O | 1974 |
26 other studies available for oxprenolol and Arrhythmias, Cardiac
| Article | Year |
|---|---|
[Abnormal ECG and adrenaline-induced arrhythmias in restraint and water immersion stressed mice and effects of oxprenolol].
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Disease Models, Animal; E | 1984 |
[The abnormal ECG and the appearance of methacholine-induced arrhythmias in SART mice and effects of beta-blockers, oxprenolol, propranolol, and carteolol].
Topics: Animals; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Carteolol; Disease Models, Animal; | 1984 |
Studies with long acting propranolol.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Delayed-Action Preparations; Half-Life; Heart Rate; Humans; H | 1984 |
Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arrhythmias, Cardiac; Female; Heart Atria; Heart R | 1977 |
[Coparative pharmacological study of new adrenergic beta receptor blocking aromatic derivatives of oxybutanolamine and trasicor].
Topics: Adrenergic beta-Antagonists; Amino Alcohols; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; | 1977 |
[beta-receptor blockaders in cardiac arrhythmias].
Topics: Adrenergic beta-Antagonists; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atenolol; Bradycardia; Electro | 1978 |
Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels | 1978 |
[Therapy of postoperative arrhythmias (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complex | 1979 |
Effect of beta receptor blockade on the initiation and perpetuation of ouabain-induced ventricular tachyarrhythmia.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Female; Heart Rate | 1975 |
[Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Drug Evaluation; Drug Synergism; Elec | 1979 |
Beta-blockade in subarachnoid haemorrhage.
Topics: Arrhythmias, Cardiac; Humans; Male; Middle Aged; Oxprenolol; Subarachnoid Hemorrhage | 1978 |
[beta Blocking agent treatment in hyperthyroidism in children].
Topics: Age Factors; Arrhythmias, Cardiac; Child; Child, Preschool; Female; Humans; Hyperthyroidism; Infant, | 1977 |
Electrophysiologic properties of intravenous oxprenolol in man.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Node; Female; Heart Conduction System; Humans; M | 1977 |
[Use of beta adrenergic receptor blockaders in the early postoperative period].
Topics: Adult; Aged; Arrhythmias, Cardiac; Drug Evaluation; Humans; Middle Aged; Oxprenolol; Pindolol; Posto | 1977 |
The R-R interval histogram.
Topics: Arrhythmias, Cardiac; Electrocardiography; Heart Rate; Humans; Male; Monitoring, Physiologic; Oxpren | 1976 |
[Trasicor in acute supraventricular arrhythmias].
Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Female; Heart Ventricles; Humans; Male | 1975 |
[Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin)].
Topics: Adult; Alprenolol; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Dogs; Enflurane; Halothane | 1975 |
Circulatory collapse after oral oxprenolol.
Topics: Arrhythmias, Cardiac; Heart Ventricles; Humans; Isoproterenol; Male; Middle Aged; Oxprenolol; Shock | 1975 |
Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group.
Topics: Arrhythmias, Cardiac; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studie | 1990 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
[Clinical pharmacology of a new beta-adrenergic blocking agent--Trasicor].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Depression, Chemical; Drug Evaluation; Heart Rate | 1973 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Fail | 1973 |
[Effects of propranolol, practolol, trasicor and visken on cardiac chronotropism and supraventricular or ventricular arrhythmias].
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Amino Alcohols; Arrhythmias, Cardiac; Evaluation S | 1972 |
[Use of trasycor in disorders of the cardiac rhythm and ischemic heart disease].
Topics: Administration, Oral; Arrhythmias, Cardiac; Coronary Disease; Humans; Oxprenolol | 1974 |
[Action of a beta-blocking agent, oxprenolol, in the treatment of rhythm disorders].
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Child; Child, Preschool; Female; Humans; Infant; Infa | 1972 |
Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Humans; Middle Aged; Myocardial Infarction; Oxprenolol | 1971 |